Fat emulsion of biobalide B and preparation method

A fat emulsion and ginkgolide technology, applied in the field of fat emulsion, can solve the problems of low bioavailability, high price, poor absorption, etc., and achieve the effects of excellent formulation characteristics, good stability and high bioavailability

Inactive Publication Date: 2006-04-19
刘晓东 +1
View PDF0 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Ginkgolide B is insoluble in water and has poor absorption in the body. Due to its high price and low bioavailability, it causes great waste. The technology of the existing preparations cannot solve the problem of poor absorption. The present invention proposes a solution to improve the bioavailability effective solution

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Fat emulsion of biobalide B and preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] Put 20g of soybean oil into the container after filtering it with a membrane filter, put 175mg of ginkgolide B into the container, stir mechanically at high temperature (200°C) until the drug is dispersed, then cool down to 95°C, put in 2g of soybean lecithin, and continue to stir mechanically until the drug is dispersed. Dissolve the phospholipids, mix well, and form a mixed solution; put 80ml of water for injection into another container, heat to 95°C, add surfactants, 4.0g of soybean lecithin, 3.5g of polysorbate 80, stir and disperse, adjust the isotonicity Glucose 2.5g, solubilizer dextran 4g, dissolved in water, filtered with a membrane filter, added therein.

[0055] Pour the water phase into the mixed oil phase under stirring again, then disperse at a high speed at 95°C and stir mechanically for 3 hours to make colostrum, adjust the pH to 7.5 with 0.1M sodium hydroxide solution, and transfer the prepared colostrum into High-pressure homogenizer, secondary homoge...

Embodiment 2

[0059] (1) 10g of soybean oil for injection is filtered through a micromembrane filter and put into the container. Ginkgolide B150mg is also put into the container, heated to 50°C and stirred evenly. Add 2.0g of soybean lecithin and continue to stir mechanically to make the mixture uniform. A mixture is formed. (2) Add 90ml of water to another preparation container, heat to 50°C, add 3.0g of soybean lecithin and 3.5g of polysorbate 80 as surfactants and stir to disperse. Glucose 2.5g and dextran 4.5g were dissolved in water, filtered through a micromembrane filter and added to the container. (3) Pour the water phase obtained in step (2) into the mixed phase obtained in step (1) under stirring, disperse at a high speed at 50°C, and stir mechanically for 2 hours to make colostrum, and oxidize it with 0.1M hydrogen The sodium solution adjusted the pH to 7.4. The uniformly dispersed emulsion is filtered through a micromembrane and then emulsified twice through a high-pressure ho...

Embodiment 3

[0061] (1) 25g of soybean oil for injection is filtered through a micromembrane filter and put into the container, and 100mg of ginkgolide B is also put into the container, heated to 50°C and stirred evenly, then 50mg of α-tocopherol is added, and mechanical stirring is continued to make the mixture evenly, A mixture is formed. (2) Add appropriate amount of water to another preparation container, heat to 50°C, add 2.0 g of soybean lecithin and 3.0 g of Pluronic F-68 and stir to disperse. Glycerin 3.0g was dissolved in water, filtered through a micromembrane filter and added to the container. (3) Pour the water phase obtained in step (2) into the mixed phase obtained in step (1) under stirring, disperse at a high speed at 50° C., and then mechanically stir for 2 hours to prepare colostrum. The uniformly dispersed emulsion is filtered through a micromembrane and then emulsified twice through a high-pressure homogenizer. Add water to 100ml under stirring, adjust PH to check the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A fatty emulsion of ginkalide B and its preparing process are disclosed. It has the strong antagonism to platelet activating factor.

Description

technical field [0001] The present invention relates to a kind of pharmaceutical preparation with strong anti-platelet activating factor (obviously anti-platelet aggregation, anti-senile dementia etc.), specifically a kind of ginkgolide B extracted from Ginkgo biloba leaves Fat emulsion of active ingredient. Background technique [0002] Ginkgo (Ginkgo Biloba L.) is a plant of the Ginkgo family, Ginkgo genus, also known as ginkgo, Gongsun tree, and widely distributed in China. Its seeds have been used as "ginkgo" for more than 600 years. It was not until the 1970s that ginkgo leaf extract was found to have good curative effects on cardiovascular and cerebrovascular diseases, and the medicinal value of ginkgo received widespread attention. [0003] Ginkgolide (ginkgolide) is one of the main active ingredients of Ginkgo biloba. In 1932, Furukawa isolated terpene lactones from Ginkgo biloba leaves for the first time. In 1967, Maruyama et al. isolated ginkgolides A, B, C and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/365A61K9/107A61P9/00
Inventor 刘晓东陈卫东
Owner 刘晓东
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap